What did the study find?
“At the conclusion of the study, only ACPA was found to be independently associated with a person's risk for the development of RA.”
Additionally, “higher ACPA levels were not associated with a significantly increased risk for progression to RA, whereas higher RF levels were.”
Findings showed that 67% of the ACPA-positive/RF-positive individuals were shown to have been at risk.
Of note, however, is that RA did not develop in >30% of ACPA-positive/RF-positive CSA patients during the 2-year follow-up.